학술논문
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial
Document Type
Article
Author
Löwenberg, Bob; Pabst, Thomas; Maertens, Johan; Gradowska, Patrycja; Biemond, Bart J.; Spertini, Olivier; Vellenga, Edo; Griskevicius, Laimonas; Tick, Lidwine W.; Jongen-Lavrencic, Mojca; van Marwijk Kooy, Marinus; Vekemans, Marie-Christiane; van der Velden, Walter J.F.M.; Beverloo, Berna; Michaux, Lucienne; Graux, Carlos; Deeren, Dries; de Weerdt, Okke; van Esser, Joost W.J.; Bargetzi, Mario; Klein, Saskia K.; Gadisseur, Alain; Westerweel, Peter E.; Veelken, Hendrik; Gregor, Michael; Silzle, Tobias; van Lammeren-Venema, Daniëlle; Moors, Ine; Breems, Dimitri A.; Hoogendoorn, Mels; Legdeur, Marie-Cecile J.C.; Fischer, Thomas; Kuball, Juergen; Cornelissen, Jan; Porkka, Kimmo; Juliusson, Gunnar; Meyer, Peter; Höglund, Martin; Gjertsen, Bjorn T.; Janssen, Jeroen J.W.M.; Huls, Gerwin; Passweg, Jakob; Cloos, Jacqueline; Valk, Peter J.M.; van Elssen, Catharina H.M.J.; Manz, Markus G.; Floisand, Yngvar; Ossenkoppele, Gert J.
Source
In Blood Advances 23 February 2021 5(4):1110-1121
Subject
Language
ISSN
2473-9529